On the stock market since 2013, it operates in the world of health and science. It has 18,819 employees. Now — the numbers.
This is an established company with proven profits.
No real growth (4% a year).
If every debt were paid off today, $207.6M would still be left in the vault — a solid cushion for hard times.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Profit per Sale: The profit kept from each sale is thin.
The stock trades below its recent peak — about 14% off the top. A pullback, not a collapse.
Over the last 3 years, sales grew about 9% a year on average.
There is $329.7M in the vault; even if every debt were paid off, $207.6M would remain.
It pays out $0.12 per share each year — regular cash for whoever holds the stock.
The company’s market value is 33 times its annual profit. Even a small disappointment could hit the price hard.
The price action doesn’t yet back an upward turn. Council score: 0/10.
As the slice kept from each sale thins out, so does the profit. Council score: 3/10.
On our five-subject report card, RKAGY sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: RKAGY is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.